In the last three months, 20 analysts have published ratings on Sage Therapeutics (NASDAQ:SAGE), offering a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 4 | 13 | 1 | 1 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 2 | 0 | 0 |
| 2M Ago | 0 | 0 | 2 | 0 | 1 |
| 3M Ago | 1 | 2 | 9 | 1 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $19.35, a high estimate of $28.00, and a low estimate of $8.00. This current average has decreased by 23.46% from the previous average price target of $25.28.
Breaking Down Analyst Ratings: A Detailed Examination
The perception of Sage Therapeutics by financial experts...
Login or create a forever free account to read this news
Sign up/Log in